Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech
Benzinga
Published Feb 15, 2024 18:39
Updated Feb 15, 2024 19:40
Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech
Benzinga - by Surbhi Jain, .
Bridgewater Associates, founded by billionaire Ray Dalio, made notable adjustments to its portfolio in the fourth quarter of 2023. The hedge fund revealed significant new bets, exits and increased stakes, providing valuable insights into its investment strategy.
Over the past few years, 74-year-old Dalio gradually scaled back his formal role at the firm. He resigned as CEO in 2017 and stepped down as co-CIO last October. He does remain involved in a more informal capacity as a CIO mentor, offering advice and meeting with investors.
Key Portfolio Changes/h2 Bridgewater initiated new positions in prominent companies, including Apple Inc (NASDAQ:AAPL), Oracle Corp (NYSE:ORCL), Crown Castle Inc (NYSE:CCI), Coterra Energy Inc (NYSE:CTRA), Wells Fargo & Co (NYSE:WFC), and Delta Air Lines, Inc. (NYSE:DAL).
In the fourth quarter, the hedge fund also closed out holdings in Netflix Inc (NASDAQ:NFLX), Thermo Fisher Scientific Inc (NYSE:TMO), Microchip Technology Inc (NASDAQ:MCHP), Akamai Technologies Inc. (NASDAQ:AKAM), and Constellation Energy Corp (NASDAQ:CEG).
Tech Sector Expansion: Nvidia Stake Up 458%/h2 A highlight of Bridgewater’s fourth-quarter moves was its remarkable 458% stake increase in chipmaker Nvidia Corp (NASDAQ:NVDA), reflecting the hedge fund’s confidence in the company’s future. This move, bringing Bridgewater’s total Nvidia holdings to 268,489 shares, aligned with Nvidia’s outstanding performance, surpassing Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) in market capitalization.
In addition to the substantial Nvidia stake increase, Bridgewater expanded its tech portfolio by adding 500,000 new shares in Alphabet, increasing its Meta Platforms Inc (NASDAQ:META) holdings and making a smaller investment in Apple. The hedge fund also maintained its position in Microsoft Corp (NASDAQ:MSFT).
Also Read: Ray Dalio’s Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings
Diversification Extends To Pharma/h2
Bridgewater’s strategic diversification extended to the pharmaceutical sector, evidenced by a new investment in Eli Lilly And Co (NYSE:LLY). The fund added 255,619 shares, demonstrating a nuanced approach to capitalize on health care trends, particularly in weight-loss drugs.
Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now
Get The App
Bridgewater Associates’ 13F changes reveal a strategic and confident investment approach, marked by sector diversification and bold bets on key players. The hedge fund’s moves provide valuable insights into its outlook and investment priorities, offering a compelling narrative for market observers and investors alike.
Now Read: INDA Outperforming BRICS Peers, Ray Dalio Says ‘India Is At A Very Special Moment’ At Davos
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read the original article on Benzinga
Written By: Benzinga
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.